Google partner and GlaxoSmithKline to join $700 million forces

Caitlin Wilson | | Health Exec | Economics

Two of the world’s biggest tech and drug companies are joining forces to found an entirely new company called Galvani Bioelectrics based on bioelectronics research.

GlaxoSmithKline and Verily Life Sciences (which is under the umbrella of Google’s parent company, Alphabet) are set to spend more than $725 million on the new venture. They’ll work in both originator companies’ hometowns of London and San Francisco.

Bioelectronic medicine focuses on manipulating the body’s electrical impulses for therapeutic ends, instead of chemical or physical mechanisms.

Check out Forbes to see more business-end details of the deal. 

Google Parent and GlaxoSmithKline Are Creating a $715 Million Bioelectronics Fi…

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Related Content

Bipartisan group of 233 House members call for Medicare reform
Wartime powers enacted to address nationwide IV fluid shortage
Cardiologist compensation still rising, especially in invasive and interventional cardiology
Baxter begins importing IV supplies as 86% of providers report shortages
CMS proposes rule to combat gray market health insurance scams
Private equity firm buys controlling stake in Surescripts

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup